Belgium· BE-AMP-SAM516791-00

Fibryga 1 g

A fibrinogen, human product containing human fibrinogen, registered in Belgium by Octapharma Benelux. The same ATC class is registered in 11 of our 19 countries.

ATC B02BB01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about human fibrinogenAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Fibrinogen, human is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BB01 (fibrinogen, human), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search fibrinogen, human products by name

Fibrinogen, human · ATC B02BB01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fibrinogen, human costs, country by country.

Normalised to the WHO defined daily dose (5 g), the median price runs from $2.30 in Czechia to $2694.05 in Switzerland — a ×1171 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Fibrinogen, human · price per daily dose (5 g)

USD · FX 28 Sept 2026

CH Switzerland$2694.05
CZ Czechia$2.30

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Human Fibrinogen
Manufacturer: Octapharma Benelux
Country: Belgium (BE)
ATC code: B02BB01
ATC class: Fibrinogen, human
Defined daily dose: 5 g, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

be_apb
3748530
be_apb
4148904
be_apb
7723182

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for fibrinogen, human.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check fibrinogen, human against other medicines How interaction checks work

Fibrinogen, human · interactions on record

2 records

2 severe

Most severe, free to view

CarfilzomibL01XG02severe
CarfilzomibL01XX45severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fibrinogen, human in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fibrinogen, human products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Fibclot, Fibryga
Bulgaria · Fibryga, Хемокомплетан P
Cyprus · Fibryga, Riastap
Czechia · Fibryga, Haemocomplettan P
Germany · Fibclot, Fibryga
Denmark · Fibclot, Fibryga
Estonia · Fibryga
Spain · Fibclot, Fibryga
Finland · Fibclot, Fibryga
France · Clottafact, Fibryga
United Kingdom (Northern Ireland) · Fibclot, Fibryga
Greece · Fibclot, Riastap
Croatia · Fibryga
Hungary · Fibclot, Fibryga
Ireland · Fibryga, Riastap
Iceland · Fibryga, Riastap
Italy · Fibriclotte, Fibryga
Lithuania · Fibryga
Luxembourg · Fibclot, Fibryga
Latvia · Fibryga
Malta · Fibryga, Riastap
Netherlands · Fibclot, Fibryga
Norway · Fibclot, Fibryga
Poland · Fibryga, Riastap
Portugal · Fibryga, Haemocomplettan
Romania · Fibryga, Haemocomplettan P
Sweden · Fibclot, Fibryga
Slovenia · Fibrema, Prufibry
Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/82ed8f03-d803-46de-85f4-13ce53b81249
GET /v1/drugs/82ed8f03-d803-46de-85f4-13ce53b81249?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Fibryga 1 g",
  "name_fr": "Fibryga 1 g",
  "name_nl": "Fibryga 1 g",
  "amp_code": "SAM516791-00",
  "strengths": [
    "1.0000",
    "300.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Human Fibrinogen",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fibrinogen, Human",
  "authorisation_numbers": [
    "BE516791"
  ]
}

API reference MCP server Plans

See everything about fibrinogen, human.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console